Mr Mo'iad Alazzam, Subspecialty Fellow in Gynaecological Oncology, Sheffield Gynaecological Cancer Centre, Royal Hallamshire, Hospital, UK
Christine Ang, Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital, Gateshead, UK
Dr Mark Beresford, Consultant Clinical Oncologist, Bristol Haematology and Oncology Centre, UK
Dr Swethajit Biswas, Clinical Senior Lecturer and Honorary Consultant in Medical Oncology, Newcastle University & Northern Centre for Cancer Care (NCCC), Sir Bobby Robson Clinical Trials Unit, Freeman Hospital, Newcastle-Upon-Tyne, UK
Dr Tony Branson, Consultant Clinical Oncologist, Northern Centre for Cancer Care, The Freeman Hospital, Newcastle upon Tyne, UK
Dr Penelope Brock, Consultant Paediatric Oncologist, Great Ormond Street Hospital for Children NHS Trust and Institute of Child Health, London, UK
Dr Ellen Copson, Consultant Medical Oncologist, Southampton Oncology Centre, Southampton General Hospital, UK
Brian R. Davidson, Consultant Surgeon, Royal Free Hospital, and Professor of Surgery, UCL, UK
Dr Bruce Dezube, Beth Israel Deaconess Medical Centre, Boston, MA, USA
Emma Edwards, Cancer Genetic Counsellor, Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK
Tim Eisen, Professor of Medical Oncology, University of Cambridge Department of Oncology, Addenbrooke's Hospital, Cambridge, UK
Professor A. Engert, German Hodgkin Study Group, Dept. I of Internal Medicine, University Hospital Cologne, Germany
Professor Edzard Ernst, Laing Chair of Complementary Medicine, Complementary Medicine, Peninsula Medical School, University of Exeter, UK
Professor Marie Fallon, St Columba's Hospice Chair of Palliative Medicine, University of Edinburgh, Edinburgh Cancer Research Centre, (CRUK), Western General Hospital, UK
Dr Daniel Ford, Consultant Clinical Oncologist, Cancer Centre, Queen Elizabeth Hospital, University Hospital, Birmingham, UK
Sophie D. Fosså, Professor, Senior Consultant, Department of Oncology, Oslo University Hospital and University of Oslo, Montebello, Norway
Dr Ian Geh, Consultant Clinical Oncologist, the Cancer Centre at the Queen Elizabeth Hospital, Birmingham, UK
Dr Paula Ghaneh, Clinical Senior Lecturer, Division of Surgery and Oncology, University of Liverpool, Liverpool, UK
Dr Nick Goulden, Consultant Haematologist, Great Ormond St Hospital, London, UK
Ioannis Gounaris, Specialist Registrar in Medical Oncology, Department of Oncology, Cambridge University NHS Trust, Addenbrookes Hospital, Cambridge, UK
Dr Deborah Gregory, Consultant Clinical Oncologist, Addenbrookes Hospital, Cambridge, UK
Professor Barry W. Hancock, OBE Emeritus Professor of Medical Oncology, Weston Park Hospital, Sheffield, UK
Dr Cathrine Holland, Clinical Lecturer, University of Manchester, Academic Unit of Gynaecology, School of Cancer and Enabling Sciences, and Honorary Consultant in Gynaecological Oncology, St Marys Hospital, Manchester, UK
Dr Sarah Jefferies, Consultant Clinical Oncologist, Addenbrooke's Hospital, Cambridge, UK
Prof Ian Judson, Consultant Medical Oncologist, Head of Sarcoma Unit, Royal Marsden Hospital, London, UK
Professor Stan Kaye, CRUK Professor of Medical Oncology, Head, Section of Medicine, Institute of Cancer Research, Head, Drug Development Unit, Royal Marsden Hospital, Surrey, UK
Dr. Beate Klimm, German Hodgkin Study Group, Dept. I of Internal Medicine, University Hospital Cologne, Germany
Dr Barry J. A. Laird, Clinician Scientist in Palliative Medicine, University of Edinburgh, Honorary Consultant in Palliative Medicine, Beatson West of Scotland Cancer Centre, Glasgow, and the Edinburgh Cancer Centre, Edinburgh, UK
Gustav Lehne, Senior Consultant, Department of Oncology, Norwegian Radium Hospital, Oslo University Hospital, Montebello, Norway
Dr Elisabeth A. Macdonald, Consultant Clinical Oncologist, Consultant Emeritus Guys Hospital London, UK
Dr Umesh Mahantshetty, Assistant Professor, Department of Radiation Oncology, Member: Gynae Working Group, Tata Memorial Hospital, India
Professor David I. Marks, Professor of Haematology and Stem Cell Transplantation, Bristol BMT Unit, University Hospitals Bristol, UK
Dr Priyanka Mehta, Consultant Haematologist, University Hospitals Bristol NHS Foundation Trust, UK
Carlo G. M. Messina, Specialist Registrar in Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy
Dr Rebecca Muirhead, Clinical Research Fellow in Clinical Oncology, The Beatson, West of Scotland Cancer Centre, Glasgow, UK
Mr Raj Naik, Consultant & Clinical Director, Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital, Gateshead, UK
Professor John P. Neoptolemos, The Owen and Ellen Evans Chair of Cancer Studies, The Liverpool Cancer Research UK Centre, Head of School of Cancer Studies, Head Division of Surgery and Oncology, Liverpool, UK
Dr. Steffen Neumann, Specialist Registrar, Hematology and Oncology, University of Goettingen, Goettingen, Germany
Dr Shibani Nicum, Consultant Medical Oncologist, University of Oxford, Department of Medical Oncology, UK
Jan Oldenburg, Department of Oncology, Oslo University Hospital, Norway
Dr Liron Pantanowitz, Assistant Professor of Pathology, Tufts University School of Medicine, Department of Pathology, Baystate Medical Centre, Springfield, MA, USA
Animesh Pardanani, Consultant, Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA
Dr Christine Parkinson, Clinical Lecturer in Medical Oncology, Addenbrooke's Hospital, Cambridge, UK
Professor Nicholas Pavlidis, Professor of Medical Oncology, Department of Medical Oncology, Medical School, University of Ioannina, Greece
Dr Alexandra Pender, Clinical Fellow, Tuveson Laboratory, CRUK Cambridge Research Institute, Cambridge, UK
George Pentheroudaki, Assistant Professor in Medical Oncology, School of Medicine, University of Ioannina, Greece
Dr Barry Pizer, Consultant Paediatric Oncologist, Oncology Unit, Alder Hey Children's Hospital, Liverpool, UK
Dr Rachel Protheroe, Consultant in Haematology and Bone Marrow Transplantation, Department of Adult Bone Marrow Transplantation, Bristol, Royal Hospital for Children, UK
Dr Amrana Qureshi, Consultant Paediatric Haematologist, Children's Hospital, John Radcliffe Infirmary, Oxford, UK
Dr Kavita Raj, Consultant Haematologist, Guys and St Thomas' NHS Foundation Trust, London, UK
S. Vincent Rajkumar, Professor of Medicine, Chair, Myeloma Amyloidosis Dysproteinemia Group, Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA
Professor Roy Rampling, Beatson West of Scotland Cancer Centre, Glasgow, UK
Dr David Sebag-Montefiore, St James's Institute of Oncology, St James's University Hospital, Leeds, UK
Professor Suresh Senan, Professor of Clinical Experimental Radiotherapy, Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands
Dr Nick Slevin, Consultant Clinical Oncologist, The Christie, Manchester, UK
Cora N. Sternberg, Chief, Department of Medical Oncology, San Camillo Forlanini Hospital, Nuovi Padiglioni, Rome, Italy
Professor Robert Thomas, Consultant Oncologist, Cranfield University, Bedford and Addenbrooke's Hospitals, Cambridge, UK
Dr Xavier Thomas, Praticien Hospitalier, Hematology Department, Leukemia Unit, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France
Prof. Lorenz Trümper, Consultant, Head of Department, Hematology and Oncology, University of Goettingen, Germany
Dr Nawaz Walji, Consultant Clinical Oncologist, University Hospitals Coventry Warwickshire NHS Trust, UK
